Pharmacokinetic Optimisation of Antibacterial Treatment in Patients with Cystic Fibrosis: Current Practice and Suggestions for Future Directions

Author： Touw D.J.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.35, Iss.6, 1998-12, pp. : 437-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients

By  

Current Drug Targets, Vol. 18, Iss. 6, 2017-03 ,pp. : 687-695

Bentham Science Publishers

Access to resources Recommend Favorite

Bayesian Optimisation of Tobramycin Dosing in Paediatric Patients with Cystic Fibrosis

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 3, 2011-09 ,pp. : 183-187

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacotherapy of postpartum depression: current practice and future directions

By Tcheremissine Oleg V   Lieving Lori M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 1999-2005

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 3, 2010-07 ,pp. : 158-172

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Future Treatment Directions in T2DM

By  

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite